Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
JNJ - Johnson & Johnson
-1.17(-0.71%)8:00:02 PM 9/30/2022
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies. Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015. Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's Baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutica.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • MACD is crossing MACD signal line at 0.1. MACD crossing signal line is bullish signal.
Stock Statistics
PE Ratio23.8
PEG Ratio2.3
P/S (ttm)5.1
Earning Growth (QoQ)7%
Revenue Growth (QoQ)
Short %1%
Held by Institutions %69%
1 Day Vol Adjusted Return-0.6
1 Month Vol Adjusted Return1.0
3 Month Vol Adjusted Return-8.8
6 Month Vol Adjusted Return-7.0
20 Days SMA Price ZScore-1.0
50 Days SMA Price ZScore-1.1
12 -26 Days PPO-0.3
1 Month Average Short Volume Ratio44.8
1 Day Volume Change ZScore-0.5
1 Month Daily Vol1.3
Related Topics

Stock news

    11 Best Dividend Paying Stocks Under $50

    In this article, we discuss the best dividend stocks under $50. You can skip our detailed analysis of dividend stocks and their returns over the years, and go directly to read 5 Best Dividend Paying Stocks Under $50. The risks of a global recession are rising, with equity markets showing their worst performance since the […]

    Prediction: This Could Be the Largest Healthcare Stock By 2042

    Over the past 20 years, medical device giant Intuitive Surgical (NASDAQ: ISRG) has substantially outperformed the market. In fact, over the next couple of decades, Intuitive Surgical has a shot at becoming the largest healthcare stock. Currently, the two largest healthcare companies are pharmaceutical giant Johnson & Johnson, with a market cap of $433 billion, and insurance specialist UnitedHealth Group, whose market cap is $475 billion.

    Johnson & Johnson unveils new name for planned consumer products spinoff

    Johnson & Johnson has chosen Kenvue as the name of its planned consumer health company, which will encompass iconic brands like Band-Aid, Tylenol, Neutrogena and Johnson’s Baby Powder. Brunswick, New Jersey-based Johnson & Johnson (NYSE: JNJ) announced last year its intention to split into two entities, one division focused on consumer brands and the other on prescription drugs and medical devices. The consumer health segment generated revenue of $14.6 billion in 2021.

    Why This Stock's 2.7% Dividend Yield Could Be the Safest on Wall Street

    Dividends are a popular wealth-building tool, but let's face it: A dividend is only as helpful as it is reliable. Chasing stocks because they have high dividend yields is a dangerous game; sometimes, a high yield reflects the market's concern that a company can't afford its payout. Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) could be your stock if dependability is your goal.

    10 Best Cheap Dividend Stocks to Buy Now

    In this article, we discuss 10 best cheap dividend stocks to buy now. You can skip our detailed analysis of the best dividend stocks and their returns over the years, and go directly to read 5 Best Cheap Dividend Stocks to Buy Now. Inflation and continuous interest rate hikes have brought dividend investing to the […]

    Is it a Good Move to Trim Your Johnson & Johnson (JNJ) Stake?

    Distillate Capital Partners LLC, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here. Through the sharp sell-off in the first half of 2022, Distillate’s U.S. FSV strategy held up better than the overall market with a decline of 15.80% net of fees vs. a 19.96% […]

    Is Johnson & Johnson a Buy?

    The healthcare giant has been a fairly stable investment this year, but does it belong in your portfolio for the long term?

    Aligos Co-Founders File Complaint Against Johnson & Johnson Alleging Fraud

    Aligos Therapeutics Inc (NASDAQ: ALGS) has filed a response to the complaint of and counterclaims against Janssen Biopharma. In November 2014, Johnson & Johnson (NYSE: JNJ) acquired Alios BioPharma Inc, a privately held infectious disease biotech, for approximately $1.75 billion in cash. Lawrence Blatt and Leonid Beigelman co-founded Alios. Following J&J's 2014 acquisition, Blatt and Beigelman become employees at Janssen. But Blatt and Beigelman left Janssen, starting Aligos Therapeutics Inc (NA

    3 Reasons Why Cathie Wood Won't Touch This Warren Buffett Stock

    The factors keeping ARK Invest's boss away might actually be reasons to buy, depending on your needs.

    11 Best Dividend Paying Stocks To Buy Now

    In this article, we discuss 11 best dividend-paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their returns, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. Dividend companies are gaining ground among investors this year as they navigate the rocky market. In times of financial […]